Bicycle Therapeutics
BCYC
99 hedge funds and large institutions have $286M invested in Bicycle Therapeutics in 2025 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 39 increasing their positions, 23 reducing their positions, and 21 closing their positions.
931% more call options, than puts
Call options by funds: $402K | Put options by funds: $39K
70% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 23
0% less capital invested
Capital invested by funds: $286M → $286M (-$719K)
6.24% less ownership
Funds ownership: 59.49% → 53.25% (-6.2%)
10% less funds holding
Funds holding: 110 → 99 (-11)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
52% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.65M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$3.41M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$1.59M |
| 4 |
Renaissance Technologies
New York
|
+$1.51M |
| 5 |
AC
Armistice Capital
New York
|
+$1.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.1M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$8.36M |
| 3 |
BNP Paribas Asset Management
Paris,
France
|
-$7.24M |
| 4 |
TCM
Tybourne Capital Management
Hong Kong
|
-$6.91M |
| 5 |
Millennium Management
New York
|
-$2.94M |
BCYC Hedge Fund Activity: Q3 2025 in Review
99 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q3 2025, worth a combined $286M — down 0.25% from $286M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of BCYC and 10 opened new positions — a net loss of 11 holders — while 23 trimmed existing stakes and 39 added.
The largest buyer was Acadian Asset Management, adding an estimated $4.65M. The largest seller was Point72 Asset Management, cutting an estimated $10.1M.
- 99 institutional investors held Bicycle Therapeutics (BCYC) as of Q3 2025, down from 110 in Q2 2025.
- Funds reported $286M of Bicycle Therapeutics stock for Q3 2025, down 0.25% quarter-over-quarter.
- 10 funds opened new Bicycle Therapeutics positions in Q3 2025 and 21 closed out, a net change of -11 holders.
- The largest Bicycle Therapeutics buyer in Q3 2025 was Acadian Asset Management, an estimated $4.65M added.
- The largest Bicycle Therapeutics seller in Q3 2025 was Point72 Asset Management, an estimated $10.1M sold.
Based on aggregated 13F filings for Q3 2025.